Research on Diet and Exercise in Ovarian Cancer
Current Issue
- Welcome
- Conference 2012
- Weight Loss Before and After Breast Cancer
- Diet and Exercise in Ovarian Cancer
- Improving Continuum of Care
- Follow-up Care
- Pelvic Health Rehabilitation
- ASCO 2012 Highlights
- Conference Sponsors
- The BROCA Test
- Genetic Research in BRCA- Negative Families
- Voices of FORCE
- DIY Guide to Genealogy
- What's New @ FORCE
New Research Study Focuses on Exercise in Ovarian Cancer Survivors
Emerging research suggests that
exercise and weight control can play
a role in breast cancer survival. But
similar studies for ovarian cancer survival
have not yet been done. A new
study from the Gynecologic Oncology
Group — a cooperative organization
of the National Cancer Institute – will
investigate whether women treated
for ovarian cancer benefit from a program
to control diet, nutrition, and
weight. The study is called LIVES (Lifestyle Intervention for
oVarian cancer Enhanced Survival) and is also known as GOG 0225. Researchers hope to recruit
over 1,000 women at study sites
around the United States. The study is
open to women who:
- have ovarian, primary peritoneal, or fallopian tube cancer in stages Stage II, III, or IV;
- have completed all primary chemotherapy and consolidation therapy (if administered) between six weeks and four months prior to enrollment;
- are in complete remission;
- have achieved a documented complete response (no clinical evidence of persistent or recurrent disease) to treatment based on a normal CA-125 test and CT scan.
Participants will be randomized to one of two groups. One group will receive a diet and physical activity plan to control weight and increase activity. Participants in this group will also receive educational materials and coaching on reading food labels, and frequent lifestyle coaching by telephone. These women will also maintain a fat gram diary and a step diary at least three times a week. The other group will receive educational materials and telephone contact every six months. Blood tests of a subset of participants will be performed at the beginning of the study and at 6-, 12-, and 24- month intervals.
Visit the study website or clinicaltrials.gov for more information and a list of study sites.
Feedback
We welcome your feedback. Please send your comments to Sue Friedman or fill out our Newsletter Feedback Form.
Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.
This site has been made possible by a generous grant from Morphotek.






